Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02685852 · ClinicalTrials.gov registry record · Phase 1
Evaluating Exenatide for the Treatment of Postprandial Hyperinsulinemic Hypoglycemia
A Phase 1 study, sponsored by University of Minnesota.
- Completed
- Registry status
- Phase 1
- Development phase
- 11
- Enrollment target
NCT02685852 is a Phase 1 study that has completed, run by University of Minnesota. The registered enrollment target is 11 participants.
The verdict
NCT02685852, a Phase 1 study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 11 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate the effectiveness of exenatide in adults experiencing episodes of hyperinsulinemic hypoglycemia following Roux-en-Y bariatric surgery.
Interventions
- DRUG Exenatide
- DRUG Acarbose
- DRUG Exenatide Placebo
- DRUG Acarbose Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2016-02 |
| Est. Completion | 2019-07-22 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02685852
The ClinicalTrials.gov registry entry for NCT02685852 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Exenatide is the first listed.
NCT02685852 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02685852 about?
NCT02685852 is a clinical study titled "Evaluating Exenatide for the Treatment of Postprandial Hyperinsulinemic Hypoglycemia". The purpose of the study is to evaluate the effectiveness of exenatide in adults experiencing episodes of hyperinsulinemic hypoglycemia following Roux-en-Y bariatric surgery.
What is the current status of trial NCT02685852?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 11 participants. The study started on 2016-02. Estimated completion is 2019-07-22.
What interventions are being tested in trial NCT02685852?
The interventions under investigation include: Exenatide (DRUG), Acarbose (DRUG), Exenatide Placebo (DRUG), Acarbose Placebo (DRUG).
Who is sponsoring clinical trial NCT02685852?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.